Clinical Perspectives. Interpretation of trials with drug and devices; a double standard?

Additional Metadata
Keywords	Angioplasty, Transluminal, Percutaneous Coronary, Coronary Artery Bypass, 0 (Anticholesteremic Agents), 81093-37-0 (Pravastatin), Anticholesteremic Agents/therapeutic use, Comparative Study, Coronary Disease/mortality/therapy, Female, Follow-Up Studies, Human, Male, Middle Aged, Pravastatin/therapeutic use, Randomized Controlled Trials/standards, Scotland, Survival Rate, Treatment Outcome
Persistent URL	hdl.handle.net/1765/5532
Journal	European Heart Journal
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Simoons, M. (1996). Clinical Perspectives. Interpretation of trials with drug and devices; a double standard?. European Heart Journal, 17, 1463–1465. Retrieved from http://hdl.handle.net/1765/5532

Publication